Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
On the signature of a 70-solar-mass black hole in LB-1.
Abdul-Masih M, Banyard G, Bodensteiner J, Bordier E, Bowman DM, Dsilva K, Fabry M, Hawcroft C, Mahy L, Marchant P, Raskin G, Reggiani M, Shenar T, Tkachenko A, Van Winckel H, Vermeylen L, Sana H. Abdul-Masih M, et al. Among authors: bodensteiner j. Nature. 2020 Apr;580(7805):E11-E15. doi: 10.1038/s41586-020-2216-x. Epub 2020 Apr 29. Nature. 2020. PMID: 32350474 No abstract available.
A massive helium star with a sufficiently strong magnetic field to form a magnetar.
Shenar T, Wade GA, Marchant P, Bagnulo S, Bodensteiner J, Bowman DM, Gilkis A, Langer N, Nicolas-Chené A, Oskinova L, Van Reeth T, Sana H, St-Louis N, de Oliveira AS, Todt H, Toonen S. Shenar T, et al. Among authors: bodensteiner j. Science. 2023 Aug 18;381(6659):761-765. doi: 10.1126/science.ade3293. Epub 2023 Aug 17. Science. 2023. PMID: 37590342
A helium-burning white dwarf binary as a supersoft X-ray source.
Greiner J, Maitra C, Haberl F, Willer R, Burgess JM, Langer N, Bodensteiner J, Buckley DAH, Monageng IM, Udalski A, Ritter H, Werner K, Maggi P, Jayaraman R, Vanderspek R. Greiner J, et al. Among authors: bodensteiner j. Nature. 2023 Mar;615(7953):605-609. doi: 10.1038/s41586-023-05714-4. Epub 2023 Mar 22. Nature. 2023. PMID: 36949334 Free PMC article.
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial.
Mah JK, Clemens PR, Guglieri M, Smith EC, Finkel RS, Tulinius M, Nevo Y, Ryan MM, Webster R, Castro D, Kuntz NL, McDonald CM, Damsker JM, Schwartz BD, Mengle-Gaw LJ, Jackowski S, Stimpson G, Ridout DA, Ayyar-Gupta V, Baranello G, Manzur AY, Muntoni F, Gordish-Dressman H, Leinonen M, Ward LM, Hoffman EP, Dang UJ; NorthStar UK Network and CINRG DNHS Investigators. Mah JK, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2144178. doi: 10.1001/jamanetworkopen.2021.44178. JAMA Netw Open. 2022. PMID: 35076703 Free PMC article. Clinical Trial.
Developing a New Set of ACGME Milestones for Child Neurology Residency.
Albert DVF, Bass N, Bodensteiner J, Draconi C, Duke ES, Felker M, Gropman A, Lotze T, Mink JW, Reese JJ Jr, Spiciarich M, Urion DK, Edgar L. Albert DVF, et al. Among authors: bodensteiner j. Pediatr Neurol. 2021 Jan;114:47-52. doi: 10.1016/j.pediatrneurol.2020.10.008. Epub 2020 Oct 24. Pediatr Neurol. 2021. PMID: 33212335
Suitability of external controls for drug evaluation in Duchenne muscular dystrophy.
Goemans N, Signorovitch J, Sajeev G, Yao Z, Gordish-Dressman H, McDonald CM, Vandenborne K, Miller D, Ward SJ, Mercuri E; investigators from PRO-DMD-01 Study, CINRG DNHS, ImagingDMD, and the DMD Italian Group. Goemans N, et al. Neurology. 2020 Sep 8;95(10):e1381-e1391. doi: 10.1212/WNL.0000000000010170. Epub 2020 Jul 1. Neurology. 2020. PMID: 32611643 Free PMC article.
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy.
Spitali P, Zaharieva I, Bohringer S, Hiller M, Chaouch A, Roos A, Scotton C, Claustres M, Bello L, McDonald CM, Hoffman EP; CINRG Investigators; Koeks Z, Eka Suchiman H, Cirak S, Scoto M, Reza M, 't Hoen PAC, Niks EH, Tuffery-Giraud S, Lochmüller H, Ferlini A, Muntoni F, Aartsma-Rus A. Spitali P, et al. Eur J Hum Genet. 2020 Jun;28(6):815-825. doi: 10.1038/s41431-019-0563-6. Epub 2020 Jan 2. Eur J Hum Genet. 2020. PMID: 31896777 Free PMC article.
Neurological Manifestations of Achondroplasia.
Bodensteiner JB. Bodensteiner JB. Curr Neurol Neurosci Rep. 2019 Nov 28;19(12):105. doi: 10.1007/s11910-019-1008-x. Curr Neurol Neurosci Rep. 2019. PMID: 31782047 Review.
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.
Conrado DJ, Larkindale J, Berg A, Hill M, Burton J, Abrams KR, Abresch RT, Bronson A, Chapman D, Crowther M, Duong T, Gordish-Dressman H, Harnisch L, Henricson E, Kim S, McDonald CM, Schmidt S, Vong C, Wang X, Wong BL, Yong F, Romero K; Duchenne Muscular Dystrophy Regulatory Science Consortium (D-RSC). Conrado DJ, et al. J Pharmacokinet Pharmacodyn. 2019 Oct;46(5):441-455. doi: 10.1007/s10928-019-09642-7. Epub 2019 May 24. J Pharmacokinet Pharmacodyn. 2019. PMID: 31127458
230 results